Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Identifieur interne : 000402 ( Main/Exploration ); précédent : 000401; suivant : 000403Discovering drugs to treat coronavirus disease 2019 (COVID-19).
Auteurs : Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine]Source :
- Drug discoveries & therapeutics [ 1881-784X ] ; 2020.
Descripteurs français
- KwdFr :
- Alanine (analogues et dérivés), Alanine (pharmacologie), Amides (pharmacologie), Antiviraux (), Antiviraux (pharmacologie), Chloroquine (pharmacologie), Découverte de médicament, Humains, Indoles (pharmacologie), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (virologie), Pyrazines (pharmacologie), Ribonucléotides (pharmacologie), Réplication virale (), Études cliniques comme sujet.
- MESH :
- analogues et dérivés : Alanine.
- pharmacologie : Alanine, Amides, Antiviraux, Chloroquine, Indoles, Pyrazines, Ribonucléotides.
- traitement médicamenteux : Infections à coronavirus.
- virologie : Infections à coronavirus.
- Antiviraux, Découverte de médicament, Humains, Réplication virale, Études cliniques comme sujet.
English descriptors
- KwdEn :
- Alanine (analogs & derivatives), Alanine (pharmacology), Amides (pharmacology), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Betacoronavirus (drug effects), Betacoronavirus (physiology), Chloroquine (pharmacology), Clinical Studies as Topic, Coronavirus Infections (drug therapy), Coronavirus Infections (virology), Drug Discovery, Humans, Indoles (pharmacology), Pyrazines (pharmacology), Ribonucleotides (pharmacology), Virus Replication (drug effects).
- MESH :
- chemical , analogs & derivatives : Alanine.
- chemical , chemistry : Antiviral Agents.
- chemical , pharmacology : Alanine, Amides, Antiviral Agents, Chloroquine, Indoles, Pyrazines, Ribonucleotides.
- drug effects : Betacoronavirus, Virus Replication.
- drug therapy : Coronavirus Infections.
- physiology : Betacoronavirus.
- virology : Coronavirus Infections.
- Clinical Studies as Topic, Drug Discovery, Humans.
Abstract
The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
DOI: 10.5582/ddt.2020.01012
PubMed: 32147628
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000184
- to stream PubMed, to step Curation: 000184
- to stream PubMed, to step Checkpoint: 000372
- to stream Ncbi, to step Merge: 000C32
- to stream Ncbi, to step Curation: 000C32
- to stream Ncbi, to step Checkpoint: 000C32
- to stream Main, to step Merge: 000404
- to stream Main, to step Curation: 000402
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Discovering drugs to treat coronavirus disease 2019 (COVID-19).</title><author><name sortKey="Dong, Liying" sort="Dong, Liying" uniqKey="Dong L" first="Liying" last="Dong">Liying Dong</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author><author><name sortKey="Hu, Shasha" sort="Hu, Shasha" uniqKey="Hu S" first="Shasha" last="Hu">Shasha Hu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author><author><name sortKey="Gao, Jianjun" sort="Gao, Jianjun" uniqKey="Gao J" first="Jianjun" last="Gao">Jianjun Gao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32147628</idno><idno type="pmid">32147628</idno><idno type="doi">10.5582/ddt.2020.01012</idno><idno type="wicri:Area/PubMed/Corpus">000184</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000184</idno><idno type="wicri:Area/PubMed/Curation">000184</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000184</idno><idno type="wicri:Area/PubMed/Checkpoint">000372</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000372</idno><idno type="wicri:Area/Ncbi/Merge">000C32</idno><idno type="wicri:Area/Ncbi/Curation">000C32</idno><idno type="wicri:Area/Ncbi/Checkpoint">000C32</idno><idno type="wicri:Area/Main/Merge">000404</idno><idno type="wicri:Area/Main/Curation">000402</idno><idno type="wicri:Area/Main/Exploration">000402</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Discovering drugs to treat coronavirus disease 2019 (COVID-19).</title><author><name sortKey="Dong, Liying" sort="Dong, Liying" uniqKey="Dong L" first="Liying" last="Dong">Liying Dong</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author><author><name sortKey="Hu, Shasha" sort="Hu, Shasha" uniqKey="Hu S" first="Shasha" last="Hu">Shasha Hu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author><author><name sortKey="Gao, Jianjun" sort="Gao, Jianjun" uniqKey="Gao J" first="Jianjun" last="Gao">Jianjun Gao</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong</wicri:regionArea><wicri:noRegion>Shandong</wicri:noRegion></affiliation></author></analytic><series><title level="j">Drug discoveries & therapeutics</title><idno type="eISSN">1881-784X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alanine (analogs & derivatives)</term><term>Alanine (pharmacology)</term><term>Amides (pharmacology)</term><term>Antiviral Agents (chemistry)</term><term>Antiviral Agents (pharmacology)</term><term>Betacoronavirus (drug effects)</term><term>Betacoronavirus (physiology)</term><term>Chloroquine (pharmacology)</term><term>Clinical Studies as Topic</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (virology)</term><term>Drug Discovery</term><term>Humans</term><term>Indoles (pharmacology)</term><term>Pyrazines (pharmacology)</term><term>Ribonucleotides (pharmacology)</term><term>Virus Replication (drug effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Alanine (analogues et dérivés)</term><term>Alanine (pharmacologie)</term><term>Amides (pharmacologie)</term><term>Antiviraux ()</term><term>Antiviraux (pharmacologie)</term><term>Chloroquine (pharmacologie)</term><term>Découverte de médicament</term><term>Humains</term><term>Indoles (pharmacologie)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Infections à coronavirus (virologie)</term><term>Pyrazines (pharmacologie)</term><term>Ribonucléotides (pharmacologie)</term><term>Réplication virale ()</term><term>Études cliniques comme sujet</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Alanine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Alanine</term><term>Amides</term><term>Antiviral Agents</term><term>Chloroquine</term><term>Indoles</term><term>Pyrazines</term><term>Ribonucleotides</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Alanine</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term><term>Virus Replication</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Alanine</term><term>Amides</term><term>Antiviraux</term><term>Chloroquine</term><term>Indoles</term><term>Pyrazines</term><term>Ribonucléotides</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Clinical Studies as Topic</term><term>Drug Discovery</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Antiviraux</term><term>Découverte de médicament</term><term>Humains</term><term>Réplication virale</term><term>Études cliniques comme sujet</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Dong, Liying" sort="Dong, Liying" uniqKey="Dong L" first="Liying" last="Dong">Liying Dong</name></noRegion><name sortKey="Gao, Jianjun" sort="Gao, Jianjun" uniqKey="Gao J" first="Jianjun" last="Gao">Jianjun Gao</name><name sortKey="Hu, Shasha" sort="Hu, Shasha" uniqKey="Hu S" first="Shasha" last="Hu">Shasha Hu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000402 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000402 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32147628
|texte= Discovering drugs to treat coronavirus disease 2019 (COVID-19).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32147628" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidV1
| This area was generated with Dilib version V0.6.33. |  |